Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
07/2001
07/12/2001WO2001049739A1 A new polypeptide-myelin p0 protein 14 and the polynucleotide encoding it
07/12/2001WO2001049738A1 A novel polypeptide - human fkbp protein 11 and a polynucleotide encoding the same
07/12/2001WO2001049737A1 A novel polypeptide - human latexin protein 46 and a polynucleotide encoding the same
07/12/2001WO2001049736A1 A new polypeptide-human rs3 protein and the polynucleotide encoding it
07/12/2001WO2001049735A1 A novel polypeptide-human g-protein and the polynucleotide encoding the same
07/12/2001WO2001049734A1 A novel polypeptide - plp protein 10 and a polynucleotide encoding the same
07/12/2001WO2001049733A1 A novel polypeptide - glucosyl hydrolase 12 and a polynucleotide encoding the same
07/12/2001WO2001049732A1 A novel polypeptide - trans-glutaminase 10 and a polynucleotide encoding the same
07/12/2001WO2001049731A1 A new polypeptide-human protease regulatory protein 9 and the polynucleotide encoding it
07/12/2001WO2001049730A1 A novel polypeptide - clathrin light chain 12 and a polynucleotide encoding the same
07/12/2001WO2001049729A2 Novex polypeptides, nucleic acids encoding same and their diagnostic and therapeutic use
07/12/2001WO2001049721A2 Bacterial genes and proteins that are essential for cell viability and their uses
07/12/2001WO2001049719A2 Activators of caspases
07/12/2001WO2001049717A2 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or t cell subset activity by modulation of xbp-1 activity
07/12/2001WO2001049715A2 Methods and compositions for inhibiting neoplastic cell growth
07/12/2001WO2001049713A2 Stabilizing peptides, polypeptides and antibodies which include them
07/12/2001WO2001049712A2 Vaccine against isav (infectious salmon anaemia virus)
07/12/2001WO2001049711A2 Nucleic acids encoding (poly)peptides having chips activity
07/12/2001WO2001049702A1 Epididymal antimicrobial peptides
07/12/2001WO2001049687A2 Cyclohexene nucleic acids
07/12/2001WO2001049416A1 Polymerase chain reaction system
07/12/2001WO2001049324A2 Novel colloid synthetic vectors for gene therapy
07/12/2001WO2001049318A1 Novel chimeric proteins and methods for using the same
07/12/2001WO2001049316A2 Use of a vector comprising a nucleic acid coding for an anti-angiogenic factor for treating corneal neovascularization
07/12/2001WO2001049312A2 O-superfamily conotoxin peptides
07/12/2001WO2001049297A1 Methods for inhibiting/treating hiv infections and aids related symptoms
07/12/2001WO2001049290A1 Methods and reagents for facilitating transcription
07/12/2001WO2001049112A2 Oocyte vitrification technique
07/12/2001WO2001049107A1 Animal models for neurodegenerative disease
07/12/2001WO2001049106A2 Method for cloning animals with targetted genetic alterations
07/12/2001WO2001049104A2 Mqm mapping using haplotyped putative qtl-alleles: a simple approach for mapping qtl's in plant breeding populations
07/12/2001WO2001049098A2 Alzheimer's disease secretase, app substrates therefor, and uses therefor
07/12/2001WO2001049097A2 Alzheimer's disease secretase, app substrates therefor, and uses therefor
07/12/2001WO2001042468A8 Human adam-ts proteases and polynucleotides encoding the same
07/12/2001WO2001023562A9 Osteoprotegerin regulatory region
07/12/2001WO2001012665A3 Helical cytokine zalpha48
07/12/2001WO2001007605A8 Immunosuppression by cell surface expression of recombinant cd154
07/12/2001WO2001006008A3 Multiplexed strand displacement for nucleic acid determinations
07/12/2001WO2001004315A3 Ringene compositions and methods for use thereof
07/12/2001WO2001004281A3 Dna coding for beta-tubulin and use thereof
07/12/2001WO2001004151A3 TUBERCULOSIS VACCINE AND DIAGNOSTICS BASED ON THE MYCOBACTERIUM TUBERCULOSIS esat-6 GENE FAMILY
07/12/2001WO2001003501A3 Non-human genetically modified mammal lacking the alpha-fetoprotein
07/12/2001WO2001002588A3 Generation of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests
07/12/2001WO2001000220A3 Lipoprotein lipase (lpl) variant therapeutics
07/12/2001WO2000077165A3 Expression in plants of starch binding domains and/or of protein fusions containing starch binding domains
07/12/2001WO2000075354A3 Adenoviral vectors encoding interferon and their use in gene therapy
07/12/2001WO2000075321A3 Polynucleotides and membrane-bound polypeptide encoded thereby
07/12/2001WO2000075278A9 Gene encoding nade, p75ntr-associated cell death executor and uses thereof
07/12/2001WO2000074724A3 Conjugates comprising cytokines and nucleic acids for treating proliferating cells
07/12/2001WO2000074722A3 Modification of biological elements
07/12/2001WO2000071711A3 Differentially expressed genes in prostate cancer
07/12/2001WO2000066786A3 Polynucleotide probes for detection and quantitation of actinomycetes
07/12/2001WO2000065070A3 Cell culture process for glycoproteins
07/12/2001WO2000063361A3 A multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides
07/12/2001WO2000061735A9 Modification of plant storage reserves
07/12/2001WO2000061230A3 Estrogen receptors-beta antagonism and bone diseases
07/12/2001WO2000055318A8 Abc1 polypeptide and methods and reagents for modulating cholesterol levels
07/12/2001WO2000053722A3 Delivery of nucleic acids and proteins to cells
07/12/2001WO2000040736A9 Molecular-biological marker for analytical electron microscopy
07/12/2001WO2000036142A9 METHOD AND KIT FOR THE CHARACTERIZATION OF ANTIBIOTIC-RESISTANCE MUTATIONS IN $i(MYCOBACTERIUM TUBERCULOSIS)
07/12/2001WO2000034447A8 Human ubiquitin ligase e3 for the modulation of nf-kappa b
07/12/2001WO2000032750A9 Transgenic circulating endothelial cells
07/12/2001WO2000017321A9 Use of growth factors and hormones for expansion of mammalian cells and tissue engineering
07/12/2001WO2000004041A3 Methods and molecules relating to cd39-like polypeptides
07/12/2001WO2000000510A3 Growth factor modulators
07/12/2001WO1999052541A3 Artery- and vein-specific proteins and uses therefor
07/12/2001US20010008026 System for tissue-restricted gene recombination
07/12/2001US20010008025 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
07/12/2001US20010007985 Method and apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing
07/12/2001US20010007902 An oligonucleotide complementary to a region of the ribonucleotide component of telomerase attached to an activator of ribonuclease L (activator-antisense complex) which cleaves ribonuclotide portion of telomerase enzyme
07/12/2001US20010007860 Immunology response
07/12/2001US20010007853 By inhalation
07/12/2001US20010007771 Cationic polymers and lipids for the delivery of nucleic acids
07/12/2001US20010007767 Genetic engineering
07/12/2001US20010007754 Isolation an antimicrobial agent; complexing with genetic engineered b-lactamase inhibitor; detection; calibration
07/12/2001US20010007752 Genetic engineering; nucleic acids
07/12/2001US20010007746 Immobilization
07/12/2001US20010007745 Genetic engineering
07/12/2001US20010007742 Probing of specific nucleic acids
07/12/2001US20010007659 Use of lentiviral vectors for antigen presentation in dendritic cells
07/12/2001US20010007656 Introducing cells treated in vivo with DNA segment comprising transcription factor gene (c-Myc) and operably linked promoter sequence to patient
07/12/2001DE19963859A1 Bi- oder Oligomer eines Di-, Tri-, Quattro- oder Pentamers von rekombinanten Fusionsproteinen Bi- or oligomer of a di-, tri-, Quattro or pentamer of recombinant fusion proteins
07/12/2001DE19963485A1 Verfahren zur Herstellung von Hydroxylnitril-Lyasen A process for preparing Hydroxylnitril lyases
07/12/2001DE19963126A1 Verfahren zur Herstellung von 6-O-alpha-D-Glucopyranosyl-D-sorbit A process for the preparation of 6-O-alpha-D-glucopyranosyl-D-sorbitol
07/12/2001DE19962828A1 Screeningsverfahren für Chemotherapeutika Screening method for chemotherapeutic agents
07/12/2001DE19962577A1 Chromatographiematerial und Verfahren unter Verwendung desselben The same chromatographic and methods using
07/12/2001DE19962154A1 Krankhaft veränderte Herzmuskelzelle, ihre Herstellung und Verwendung Diseased heart muscle cell, their preparation and use
07/12/2001DE19961899A1 Interaktikonsproteine für STAT Transkriptionsfaktor Interaktikonsproteine ​​for STAT transcription factor
07/12/2001CA2654770A1 Increased lysine production by gene amplification
07/12/2001CA2402360A1 Novel human proteases and polynucleotides encoding the same
07/12/2001CA2402131A1 Methods and compositions for determining the purity of chemically synthesized nucleic acids
07/12/2001CA2396798A1 Recombinant pinoresinol/lariciresinol reductase, recombinant dirigent protein, and methods of use
07/12/2001CA2396529A1 O-superfamily conotoxin peptides
07/12/2001CA2396523A1 Method for obtaining plants enriched in cysteine and glutathione content
07/12/2001CA2396422A1 Preparation of deallergenized proteins and permuteins
07/12/2001CA2396401A1 Novel fgf homolog zfgf12
07/12/2001CA2396364A1 Epididymal antimicrobial peptides
07/12/2001CA2396301A1 Method for concurrent amplification and real time detection of polymorphic nucleic acid sequences
07/12/2001CA2396240A1 Methods for inhibiting/treating hiv infections and aids related symptoms
07/12/2001CA2396219A1 Oocyte vitrification technique